Hypro Diagnostics has developed a rapid and cost-effective multiplex RT-PCR (mRT-PCR) assay for the detection of genomic segments of H3N2 CIV. The assay’s efficacy was thoroughly assessed using a diverse set of forty-six influenza A viruses from different hosts. Utilizing three primer sets to simultaneously amplify four segments of H3N2 CIV, this innovative method demonstrated impressive success in identifying viral segments. Its robust performance not only accelerates the diagnosis of H3N2 CIV and its reassortants but also positions it as a valuable asset in virological diagnostics within the expertise of Hypro Diagnostics.
Reviews
There are no reviews yet.